Covid-19 Vaccine Soberana 2:
Cuba has said its homegrown Covid-19 vaccine Soberana 2 (Sovereign 2), when delivered with a booster shot of Soberana Plus, is about 91 percent effective against symptomatic Covid-19 cases as demonstrated in its late stage clinical trials.
- If approved, Cuba will become the first Latin American country to manufacture and produce a vaccine against Covid-19.
- The Soberana 2 is delivered through a three dose regimen. Two shots of Soberana 2 and one of Soberana Plus, when taken in a 0-28-56 day regimen, have an efficacy of 91.2 percent, the Cuban government’s Covid-19 task force announced
- It is a protein vaccine, which is to say that these vaccines are made up of a protein derived from the virus, which then binds to human cells to trigger an immune response.